InvestorsHub Logo
icon url

biopharm

08/30/15 10:22 AM

#232810 RE: Couch #232809

And Bavi Phase II did not fail- if was successful even with botched data- allowing for phase 3 to commence.



Couch, you are correct! Even after sabotage, Peregrine recovered and salvaged the data and it still was significantly better = 60%.

I think we all wonder how good the data was if it was not tainted with and sabotaged. 200% or better is my guess
icon url

revenue_monster

08/30/15 12:00 PM

#232819 RE: Couch #232809

To be fair couch. MSK and AZ have very little skin in the game. Still positive events however all being funded by pphm.
icon url

PPHMVERYLONG

08/30/15 4:52 PM

#232841 RE: Couch #232809




Pancreatic trial and the headline was:


Celgene succeeds, Peregrine fails.


MSK & AZN mean nothing at this point, those trials are years away from data. And if Phase III fails, we will not be around to get money from anyone.